Bayesian Capital Management’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,300
Closed -$595K 836
2025
Q2
$595K Buy
+33,300
New +$650K 0.09% 253
2025
Q1
Sell
-33,600
Closed -$397K 1013
2024
Q4
$397K Sell
33,600
-82,600
-71% -$1.02M 0.05% 421
2024
Q3
$1.42M Buy
116,200
+5,200
+5% +$43.1K 0.17% 182
2024
Q2
$814K Buy
111,000
+52,600
+90% +$415K 0.09% 277
2024
Q1
$449K Sell
58,400
-40,996
-41% -$397K 0.04% 460
2023
Q4
$1.45M Buy
+99,396
New +$1.58M 0.15% 168
2023
Q3
Sell
-32,900
Closed -$442K 1052
2023
Q2
$442K Sell
32,900
-80,100
-71% -$789K 0.05% 437
2023
Q1
$1.26M Sell
113,000
-127,631
-53% -$1.23M 0.16% 197
2022
Q4
$2.39M Buy
+240,631
New +$2.17M 0.35% 44
2022
Q1
Sell
-21,800
Closed -$1.1M 947
2021
Q4
$1.1M Sell
21,800
-156
-0.7% -$7.03K 0.35% 79
2021
Q3
$780K Buy
+21,956
New +$872K 0.23% 121
2021
Q2
Sell
-16,723
Closed -$611K 681
2021
Q1
$611K Sell
16,723
-477
-3% -$19.8K 0.14% 189
2020
Q4
$737K Buy
17,200
+600
+4% +$22K 0.19% 155
2020
Q3
$333K Buy
+16,600
New +$325K 0.08% 325

Other funds holding XPEV

Bayesian Capital Management's XPEV Position: Q3 2025 in Review

Bayesian Capital Management sold out of XPeng (XPEV) in Q3 2025, closing a stake of 33,300 shares — an estimated $595K sold.

Bayesian Capital Management first reported a position in XPEV in Q3 2020 and held it in 14 quarters. The position peaked at $2.39M in Q4 2022. 226 funds tracked by Wall St. Rank hold XPEV as of Q3 2025.

  • Bayesian Capital Management reported no remaining XPeng position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 33,300 XPeng shares in Q3 2025, an estimated $595K.
  • Bayesian Capital Management first reported a position in XPeng in Q3 2020 and held it in 14 quarters.
  • Bayesian Capital Management's XPeng position peaked at $2.39M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held XPeng as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.